150 related articles for article (PubMed ID: 31398513)
21. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
22. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
23. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic diagnosis and photodynamic therapy in basal cell carcinoma using a novel laser light source.
Woźniak Z; Trzeciakowski W; Chlebicka I; Ziółkowski P
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101883. PubMed ID: 32574799
[TBL] [Abstract][Full Text] [Related]
25. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
[TBL] [Abstract][Full Text] [Related]
26. [Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (PhotoDyn 501): practical experiences in problem-patients with actinic keratoses and basal cell carcinomas].
Kreutzer K; Bonnekoh B; Franke I; Gollnick H
J Dtsch Dermatol Ges; 2004 Dec; 2(12):992-9. PubMed ID: 16285312
[TBL] [Abstract][Full Text] [Related]
27. 5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
Griškjans Ž; Derjabo A; Čēma I
Stomatologija; 2013; 15(1):32-6. PubMed ID: 23732828
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid.
Soler AM; Warloe T; Tausjø J; Giercksky KE
Acta Oncol; 2000; 39(5):605-9. PubMed ID: 11093368
[TBL] [Abstract][Full Text] [Related]
29. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis.
Foley P
Australas J Dermatol; 2005 Feb; 46 Suppl 3():S8-10; discussion S23-5. PubMed ID: 15859301
[No Abstract] [Full Text] [Related]
31. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
32. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
33. Topical photodynamic therapy significantly reduces epidermal Langerhans cells during clinical treatment of basal cell carcinoma.
Evangelou G; Farrar MD; Cotterell L; Andrew S; Tosca AD; Watson RE; Rhodes LE
Br J Dermatol; 2012 May; 166(5):1112-5. PubMed ID: 22242712
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy as a treatment option for multiple pigmented basal cell carcinoma: Long-term follow-up results.
Salvio AG; Requena MB; Stringasci MD; Bagnato VS
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102154. PubMed ID: 33348074
[TBL] [Abstract][Full Text] [Related]
35. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
36. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.
Souza CS; Felicio LB; Ferreira J; Kurachi C; Bentley MV; Tedesco AC; Bagnato VS
Photodiagnosis Photodyn Ther; 2009; 6(3-4):207-13. PubMed ID: 19932453
[TBL] [Abstract][Full Text] [Related]
39. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
40. Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas.
Rizzo JM; Segal RJ; Zeitouni NC
Photodiagnosis Photodyn Ther; 2018 Mar; 21():58-62. PubMed ID: 29102653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
